MedTrace Logo

Skin Protection During Radiotherapy in Patients With Breast Cancer

NCT02334345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-03-14

No results posted yet for this study

Summary

Radiotherapy may cause severe skin changes that significantly interfere with the patient's quality of life and may reduce radiotherapy effectiveness. Many skin care instructions and various topical agents are recommended to help patients in the management of radiation skin reactions, but evidence to support the value of the topical treatments of the irradiated skin is lacking. In the present study we investigated the effects of two topical agents used as supportive care to protect skin during radiotherapy.

Conditions

  • Radiation Dermatitis

Interventions

DRUG

Evoskin

Evoskin is Trixiera is a topical agent recommended to help patients in the management of radiation skin reactions

DRUG

Trixiera

Trixiera is a topical agent recommended to help patients in the management of radiation skin reactions

Sponsors & Collaborators

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Pierre CLAVRE, MD · CHU LIMOGES

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-11-01
Completion
2021-01-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02334345 on ClinicalTrials.gov